Glutathione-S-transferase-pi (GST-pi) expression in renal cell carcinoma

Main Article Content

Christina Kaprilian
Maria Horti
Kosmas Kandilaris
Andreas Skolarikos
Nikolaos Trakas
Ioannis Kastriotis
Charalambos Deliveliotis


Glutathione-s-transferase, GST-pi, immunohistochemistry, multidrug resistance, renal cell carcinoma


Multidrug resistance correlates with unfavourable treatment outcomes in numerous cancers including renal cell carcinoma. The expression and clinical relevance of Glutathione-S-transferase-pi (GST-pi), a multidrug resistance factor, in kidney tumors remain controversial. We analyzed the expression of GST-pi in 60 formalin-fixed, paraffin-embedded renal cell carcinoma samples by immunohistochemistry and compared them with matched normal regions of the kidney. A significantly higher expression of GST-pi was observed in 87% of clear cell carcinoma and 50% of papillary subtypes. GST-pi expression did not correlate with tumor grade or patient survival. GST-pi is unlikely to be a prognostic factor for renal cell carcinoma. However, further studies with large number of samples are warranted to establish the role of GST-pi, if any, in intrinsic or acquired resistance of renal cell carcinoma to conventional treatments. 

Supplementary files: The supplementary files of this article are found under 'Article Tools' at the left side bar.

Abstract 2211 | HTML Downloads 1759 PDF Downloads 694 Patient data Downloads 0